[Federal Register: September 15, 2008 (Volume 73, Number 179)]
[Notices]               
[Page 53262]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15se08-83]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration

 
Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Drug Testing Advisory Board (DTAB) will meet on September 29, 2008 from 
10 a.m. to 5 p.m. via video teleconference.
    The DTAB will meet to provide an initial briefing to members 
regarding the proposed Final Notice for Revisions to the Mandatory 
Guidelines for Federal Workplace Drug Testing Programs. This meeting 
will be conducted in closed session since the public comment period has 
ended and it is not appropriate to receive further public comments in 
an open session. An open session will significantly frustrate the 
Department's ability to prepare for and participate in the internal 
review of the proposed Revisions. The meeting will be closed to the 
public as determined by the SAMHSA Administrator in accordance with 
Title 5 U.S.C. Section 552b(c)(6), 552b(c)(9)(B), and 5 U.S.C. App. 2 
Sec.  10(d).
    Substantive program information and a roster of Board members may 
be obtained as soon as available after the meeting, either by accessing 
the SAMHSA Committee Web site at https://www.nac.samhsa.gov/DTAB/
index.aspx or by contacting DTAB's Program Assistant, Ms. Giselle Hersh 
(see contact information below)

    Committee Name: Substance Abuse and Mental Health Services 
Administration, Drug Testing Advisory Board.
    Date/Time/Type: September 29, 2008, from 10 a.m. to 5 p.m.: 
Closed.
    Place: 1 Choke Cherry Road, VTC Conference Room, L-1057, 
Rockville, Maryland 20857.
    Contact: Ms. Giselle Hersh, Program Assistant, SAMHSA Drug 
Testing Advisory Board, 1 Choke Cherry Road, Room 2-1042, Rockville, 
Maryland 20857, Telephone: 240-276-2600, Fax: 240-276-2610, E-mail: 
Giselle.Hersh@samhsa.hhs.gov.

Toian Vaughn,
Committee Management Officer, Substance Abuse and Mental Health 
Services Administration.
[FR Doc. E8-21236 Filed 9-12-08; 8:45 am]

BILLING CODE 4162-20-P